CRWM
ABBV icon

Castle Rock Wealth Management’s AbbVie ABBV Stock Holding History

Castle Rock Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,200
Closed -$1K – 159
2019
Q2 		$1K Buy
+1,200
New +$94.3K ﹤0.01% 145

Other funds holding ABBV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Castle Rock Wealth Management's ABBV Position: Q3 2026 in Review

Castle Rock Wealth Management reduced its AbbVie (ABBV) stake by 21% in Q3 2026, selling an estimated $81.3K and leaving 1,198 shares worth $320K. The position accounts for 0.06% of the portfolio, ranked #215.

Castle Rock Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 26 quarters since. The position peaked at $1.38M in Q4 2024. 672 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Castle Rock Wealth Management held 1,198 shares of AbbVie worth $320K as of Q3 2026.
  • Castle Rock Wealth Management sold 317 AbbVie shares in Q3 2026, an estimated $81.3K.
  • AbbVie made up 0.06% of Castle Rock Wealth Management's portfolio in Q3 2026, its #215 holding.
  • Castle Rock Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 26 quarters since.
  • Castle Rock Wealth Management's AbbVie position peaked at $1.38M in Q4 2024.
  • 672 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Castle Rock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.